Infectious etiology of acute exacerbations in severe COPD patients

Arnau Domenech1, Carmen Puig, Sara Martí

  • 1Department of Microbiology, Hospital Universitari de Bellvitge, IDIBELL, University of Barcelona, Barcelona, Spain; CIBERES (Ciber de Enfermedades Respiratorias), ISCIII, Madrid, Spain.

The Journal of Infection
|September 24, 2013
PubMed

Insights

The bacterial causes of acute exacerbations in severe COPD differ based on annual episode frequency. Pseudomonas aeruginosa is the most common pathogen overall, but specific bacteria are linked to single versus multiple exacerbations.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Microbiology

Background:

  • Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) significantly impact patient outcomes.
  • Understanding the etiology of AECOPD is crucial for effective management, especially in severe cases.
  • Limited data exist on the specific pathogens causing AECOPD in patients with varying annual exacerbation frequencies since the updated GOLD guidelines.

Purpose of the Study:

  • To investigate the etiological differences in AECOPD among severe COPD patients based on their annual frequency of exacerbations.
  • To identify the predominant bacterial pathogens associated with single versus multiple AECOPD episodes.

Main Methods:

  • Prospective follow-up of 111 severe COPD patients (FEV1 < 50%) over one year.
  • Collection and processing of sputum samples during AECOPD episodes.
  • Utilized quantitative culture and PCR for bacterial identification, including atypical bacteria.

Main Results:

  • 188 sputum samples were analyzed from 111 patients, categorized into single (40 patients) and recurrent (≥2 episodes, 71 patients) exacerbators.
  • Pseudomonas aeruginosa was the most frequently isolated pathogen (54/188 episodes).
  • Haemophilus influenzae was more common in patients with single AECOPD (33% vs. 16%), while Enterobacteriaceae were associated with frequent exacerbators (0% vs. 12%).

Conclusions:

  • Pseudomonas aeruginosa is the leading cause of AECOPD in severe COPD patients.
  • The bacterial etiology of AECOPD varies significantly depending on whether patients experience single or multiple exacerbations annually.
  • These findings highlight the need for tailored diagnostic and therapeutic approaches based on exacerbation frequency.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation